Spotlight Therapeutics
Hayward
About Spotlight Therapeutics
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $80.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2022)
- Website: spotlighttx.com
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/spotlight-therapeutics-2744 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.